For the quarter ended June 2026, Encompass Health (EHC Quick QuoteEHC - Free Report) reported revenue of $1.6 billion, up 9.6% over the same period last year. EPS came in at $1.55, compared to $1.40 in the year-ago quarter.

The reported revenue represents a surprise of +1.52% over the Zacks Consensus Estimate of $1.57 billion. With the consensus EPS estimate being $1.48, the EPS surprise was +4.73%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Encompass Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Net patient revenue per discharge: $22,521.00 compared to the $22,065.23 average estimate based on two analysts.
• Discharges: 68,895 versus 69,042 estimated by two analysts on average.
• Net Operating Revenues- Inpatient: $1.55 billion compared to the $1.52 billion average estimate based on two analysts. The reported number represents a change of +9.8% year over year.
• Net Operating Revenues- Other: $45.8 million versus $47.42 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +4.1% change.

View all Key Company Metrics for Encompass Health here>>>

Shares of Encompass Health have returned -0.2% over the past month versus the Zacks S&P 500 composite's +3.5% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.